BioXcel Therapeutics Inc
Biotechnology
Healthcare
BTAI
2.54 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.75
52 week high
6.80
high
2.83
52 week low
0.00
low
2.47
growth
3.78 %
previous Close
2.78
P/E ratio
-1
market cap
41.18 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-2.45 %
-63.33 %
eps surprise
-56.72 %
net profit margin
0.00 %
4317.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top